Clinical trials

Condition   Drug Name  
Study Thalidomide in erythema
Patients 2
Treatment Regimen Thalidomide, 50 mg/d (n=1); Thalidomide, 50 mg/d --> 3x/wk (n=1)
Conclusions Thalidomide induced rapid resolution of skin lesions in two patients with erythema multiforme major
Reference(s) Treatment of erythema multiforme major with thalidomide: A report of two cases
Br J Dermatol 2007, 157 (Suppl. 1):Abst P-102.
Author and Affiliation Leitch, C., Jury, C.